Skip to main content
. Author manuscript; available in PMC: 2021 Jun 22.
Published in final edited form as: Chin Clin Oncol. 2019 Aug;8(4):44. doi: 10.21037/cco.2019.08.14

Figure 1.

Figure 1

A 73-year-old female with metastatic retroperitoneal lymphadenopathy from gallbladder carcinoma with HER 2/neu amplification. Axial contrast-enhanced CT images demonstrate: (A) a 1.9-cm lymph node (arrow) posterior to the left renal vein. After 2 months of trastuzumab + pertuzumab, lymphadenopathy is decreased: (B) the lymph node (arrow) posterior to the left renal vein now measures 1.2 cm.